Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for SCI Neuropathic Pain
NCT01579500Phase 4Completed
- Sponsor
- Catholic University of Korea St. Paul's Hospital
- Start
- Apr 2012
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in neuropathic pain, sponsored by Catholic University of Korea St. Paul's Hospital. Primary endpoint: Visual Analogue Scale at 4 weeks. Started Apr 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01579500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579500.